Cargando…
Drug Discovery via Human-Derived Stem Cell Organoids
Patient-derived cell lines and animal models have proven invaluable for the understanding of human intestinal diseases and for drug development although both inherently comprise disadvantages and caveats. Many genetically determined intestinal diseases occur in specific tissue microenvironments that...
Autores principales: | Liu, Fangkun, Huang, Jing, Ning, Bo, Liu, Zhixiong, Chen, Shen, Zhao, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032635/ https://www.ncbi.nlm.nih.gov/pubmed/27713700 http://dx.doi.org/10.3389/fphar.2016.00334 |
Ejemplares similares
-
Organoids and Microphysiological Systems: New Tools for Ophthalmic Drug Discovery
por: Bai, Jing, et al.
Publicado: (2020) -
Tranylcypromine Causes Neurotoxicity and Represses BHC110/LSD1 in Human-Induced Pluripotent Stem Cell-Derived Cerebral Organoids Model
por: Huang, Jing, et al.
Publicado: (2017) -
Immune Checkpoint in Glioblastoma: Promising and Challenging
por: Huang, Jing, et al.
Publicado: (2017) -
Applications of organoid technology to brain tumors
por: Wen, Jie, et al.
Publicado: (2023) -
Human Pluripotent Stem Cells for Modeling of Anticancer Therapy-Induced Cardiotoxicity and Cardioprotective Drug Discovery
por: Keung, Wendy, et al.
Publicado: (2021)